|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM341665657 |
003 |
DE-627 |
005 |
20231226012312.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2022.109046
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1138.xml
|
035 |
|
|
|a (DE-627)NLM341665657
|
035 |
|
|
|a (NLM)35644521
|
035 |
|
|
|a (PII)S1521-6616(22)00127-9
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Xi, Yue
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Impaired HPV-specific T-cell response in juvenile-onset recurrent respiratory papillomatosis patients
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 09.08.2022
|
500 |
|
|
|a Date Revised 25.08.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2022 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Immunologic dysfunction is one of the most important mechanisms underlying the initiation and development of JORRP. The study aimed to explore whether HPV-specific T-cell response was impaired in JORRP patients. We found JORRP patients had a Th2-biased cytokine profile correlated with disease severity in peripheral system. JORRP patients had an increased memory T cells and a reduced naive T cells in circulation. Upon HPV6/11 antigens stimulation, T cells from JORRP patients exhibited a greater activation profile. Of note, JORRP patients presented with a greater number of IL-10- and IL-4-secreting HPV6/11 antigen responding cells than that of IFN-γ and TNF-α secreting responders. Furthermore, in response to HPV6/11 antigen stimulation, JORRP patients showed a reduced level of cell proliferation, an increased level of apoptosis and higher percentage of the differentiated T cells expressing the replicative senescent cell marker CD57. Impaired HPV-specific T-cell responses could be partly responsible for JORRP development
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Cytokine
|
650 |
|
4 |
|a HPV
|
650 |
|
4 |
|a Immune imbalance
|
650 |
|
4 |
|a JORRP
|
650 |
|
4 |
|a T-cell response
|
700 |
1 |
|
|a Wang, Wei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Hua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Xiaolin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Jie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhao, Jing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Guixiang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gui, Jingang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ni, Xin
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 241(2022) vom: 01. Aug., Seite 109046
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:241
|g year:2022
|g day:01
|g month:08
|g pages:109046
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2022.109046
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 241
|j 2022
|b 01
|c 08
|h 109046
|